Lucy Wortham James Lecture. Subclinical disease

Area of Science:

• Oncology
• Radiation Oncology
• Surgical Oncology

Background:

• Many cancer patients develop metastases in draining lymphatics that are initially clinically negative.
• Occult deposits represent subclinical disease in palpable lymphatic areas (neck, axillae, groin).
• Microscopic disease remaining after surgery can lead to recurrence, even when gross cancer is removed.

Purpose of the Study:

• To define the concept of subclinical disease in oncology.
• To explore the radiobiological implications of subclinical disease.
• To outline the clinical applications of the subclinical disease concept in cancer treatment.

Main Methods:

• Literature review and conceptual analysis of subclinical disease in cancer.
• Discussion of radiobiological parameters relevant to subclinical disease eradication.
• Analysis of treatment implications for radiation therapy and chemotherapy.

Main Results:

• Subclinical disease refers to disease in a specific anatomic area based on clinical findings.
• Subclinical disease requires less irradiation for eradication compared to gross cancer.
• The concept guides elective irradiation of clinically negative lymphatics and locoregional treatment with surgery.

Conclusions:

• Subclinical disease has significant implications for radiation therapy planning and delivery.
• Understanding subclinical disease impacts the integration of chemotherapy with radiation and surgery.
• The concept is crucial for optimizing cancer treatment strategies and improving patient outcomes.